Evista (Raloxifene) is a selective estrogen receptor modulator (SERM) used in the prevention and treatment of osteoporosis.
Disclaimer
The content in this page is not a substitute for professional medical advice. Please contact your doctor before taking Evista (Raloxifene).
References
Fast Facts
-
Pronounced
ee-VIS-tuh
-
Mechanism of action
SERMs mimic estrogen's effects on bone, which reduces bone resorption and increases bone formation.
-
Common side effects
Hot flashes, sweating, leg cramps, blood clots, weight gain, depression, insomnia
-
Clinical trials
STAR Trial showed Evista (Raloxifene) was as effective at preventing breast cancer as Tamoxifen, but with a reduced risk of cataracts or DVTs.
-
News
September 14, 2007, the FDA approved Evista (Raloxifene) for reducing the risk of invasive breast cancer in postmenopausal women with osteoporosis.
